Atrial Fibrillation Screening-to-Anticoagulation Pathways in Low- and Middle-Income Countries
BACKGROUND: Atrial fibrillation (AF) is an important cause of preventable stroke in low- and middle-income countries (LMICs), where diagnostic and treatment gaps may limit screening effectiveness. OBJECTIVES: This study aims to evaluate AF screening in LMICs as a screening-to-anticoagulation pathway, focusing on reach, equity, diagnostic confirmation, anticoagulation uptake, and health-system capacity. METHODS: MEDLINE via PubMed, Embase, CINAHL, Web of Science, and CENTRAL were searched from inception to July 2026. LMIC studies reporting population-facing AF screening or screening-linked care were included. Logit-transformed proportions were pooled using restricted maximum-likelihood random-effects models with modified Hartung-Knapp CIs; binomial-normal generalized linear mixed models were used in sensitivity analyses. Pathway stages were synthesized from outcome-specific study subsets rather than a single longitudinal cohort. RESULTS: = 99.2%; prediction interval: 0.08%-9.97%). In separate study subsets, prior AF awareness was 50.7%, study-defined high stroke risk or oral anticoagulation indication was 78.9%, and oral anticoagulation coverage among study-defined eligible/high-risk participants was 22.8%. Reach ranged from 9.7% to 98.8%, and confirmation completion was 57.5% to 61.8% in 2 programs. CONCLUSIONS: AF screening in LMICs identifies substantial but highly variable detection and treatment gaps. Pooled proportions should be interpreted as cross-study summaries rather than expected rates for a specific setting. Effective programs require representative reach, timely confirmation, appropriate stroke-risk and valvular assessment, access to anticoagulation, and longitudinal follow-up.
Authors
- G. André Ng (ORCID: https://orcid.org/0000-0001-5965-0671)
- Kaveh Hosseini (ORCID: https://orcid.org/0000-0001-5676-3099)
- Mirvat A. Alasnag (ORCID: https://orcid.org/0000-0002-8714-0334)
- Sadeer G Al-Kindi (ORCID: https://orcid.org/0000-0002-1122-7695)
- Zainab Atiyah Dakhil (ORCID: https://orcid.org/0000-0001-7102-522X)
- Marwan M. Refaat (ORCID: https://orcid.org/0000-0002-3210-1987)
- W M Al Mahmeed
- Mustafa Zakkar (ORCID: https://orcid.org/0000-0001-5810-4679)
- Eyad Jamileh (ORCID: https://orcid.org/0000-0002-1006-9824)
- Ibrahim Antoun (ORCID: https://orcid.org/0000-0002-4374-7476)
- Fahad Muhammad (ORCID: https://orcid.org/0009-0007-5554-5293)
- Omar Farooq (ORCID: https://orcid.org/0009-0007-0891-2986)
- Jassim Al Suwaidi
- Riyaz Somani
Institutions
- University of Copenhagen (DK)
- Houston Methodist (US)
- University of Baghdad (IQ)
- University of Leicester (GB)
- University Hospitals of Morecambe Bay NHS Foundation Trust (GB)
- University of Lancashire (GB)
- Glenfield Hospital (GB)
- University Hospitals of Leicester NHS Trust (GB)
- Copenhagen University Hospital (DK)
- Gentofte Hospital (DK)
- King Fahd Armed Forces Hospital (SA)
- Royal Blackburn Teaching Hospital (GB)
- Cleveland Clinic Abu Dhabi (AE)
- Hamad Medical Corporation (QA)
- East Lancashire Hospitals NHS Trust (GB)
- American University of Beirut (LB)
Publication Details
- Journal
- JACC Advances
- Published
- 2026-11-16
- DOI
- https://doi.org/10.1016/j.jacadv.2026.103479
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- British Heart Foundation
- Medical Research Council